Market Exclusive

Analyst Activity – HC Wainwright Raises Its Price Target On Cytokinetics (NASDAQ:CYTK) to

Analyst Ratings For Cytokinetics (NASDAQ:CYTK)

Today, HC Wainwright raised its price target on Cytokinetics (NASDAQ:CYTK) to per share.

Some recent analyst ratings include

Recent Insider Trading Activity For Cytokinetics (NASDAQ:CYTK)
Cytokinetics (NASDAQ:CYTK) has insider ownership of 7.20% and institutional ownership of 73.61%.

Recent Trading Activity for Cytokinetics (NASDAQ:CYTK)
Shares of Cytokinetics closed the previous trading session at 8.88 up +0.07 0.85% with shares trading hands.

Exit mobile version